PLEIOTROPIC PATHWAY MODIFIER Trademark

Trademark Overview

On Tuesday, May 29, 2012, a trademark application was filed for PLEIOTROPIC PATHWAY MODIFIER with the United States Patent and Trademark Office. The USPTO has given the PLEIOTROPIC PATHWAY MODIFIER trademark a serial number of 85637111. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 16, 2014. This trademark is owned by Celgene Corporation. The PLEIOTROPIC PATHWAY MODIFIER trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

biomedical compounds used for laboratory or research use in developing pharmaceuticals for use in the field of oncology and inflammatory diseases

chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and inflammatory diseases
pleiotropic pathway modifier

General Information

Serial Number85637111
Word MarkPLEIOTROPIC PATHWAY MODIFIER
Filing DateTuesday, May 29, 2012
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, May 16, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesbiomedical compounds used for laboratory or research use in developing pharmaceuticals for use in the field of oncology and inflammatory diseases
Goods and Serviceschemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and inflammatory diseases

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, June 5, 2012
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 5, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, May 16, 2014ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, May 16, 2014ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, October 18, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 18, 2013FINAL REFUSAL E-MAILED
Friday, October 18, 2013FINAL REFUSAL WRITTEN
Thursday, September 26, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 26, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 18, 2013ASSIGNED TO LIE
Thursday, September 12, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 5, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 5, 2013NON-FINAL ACTION E-MAILED
Thursday, September 5, 2013NON-FINAL ACTION WRITTEN
Wednesday, August 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 14, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 14, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 21, 2013NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, March 20, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2013NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2013NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2013USE AMENDMENT ACCEPTED
Wednesday, February 27, 2013AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, February 27, 2013USE AMENDMENT FILED
Thursday, February 21, 2013TEAS AMENDMENT OF USE RECEIVED
Friday, February 15, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 15, 2013NON-FINAL ACTION E-MAILED
Friday, February 15, 2013NON-FINAL ACTION WRITTEN
Tuesday, January 22, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 22, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 22, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 30, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 30, 2012NON-FINAL ACTION E-MAILED
Monday, July 30, 2012NON-FINAL ACTION WRITTEN
Monday, July 23, 2012ASSIGNED TO EXAMINER
Tuesday, June 5, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 1, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

modifier pathway pleiotropic inflammatory diseases preparations chemical pharmaceutical purposes cancer treatment namely oncology